Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousTransplantation ConditioningHematopoietic Stem Cell MobilizationStem Cell TransplantationHematopoietic Stem CellsHematologic NeoplasmsGranulocyte Colony-Stimulating FactorGraft vs Host DiseaseMelphalanAntigens, CD34Combined Modality TherapyLeukapheresisBlood Component RemovalMultiple MyelomaMyeloablative AgonistsBusulfanCyclophosphamideBone Marrow TransplantationTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsGraft SurvivalStem CellsLymphoma, Non-HodgkinRemission InductionRecurrenceEtoposideTransplantation ChimeraThiotepaHematopoiesisAntineoplastic Agents, AlkylatingCord Blood Stem Cell TransplantationTissue DonorsSalvage TherapyRetrospective StudiesCarmustineWhole-Body IrradiationDisease-Free SurvivalCytophagocytosisHistocompatibilityHistocompatibility TestingCytarabineVincristineIfosfamideSurvival RateHodgkin DiseaseAmyloidosisTime FactorsSurvival AnalysisGranulocytesLeukemiaNeoplasmsImmunosuppressive AgentsGraft vs Leukemia EffectLeukemia, Myeloid, AcuteInfectionVidarabineTransplantation, IsogeneicLiver TransplantationLymphoma, T-CellFollow-Up StudiesPlatelet CountMyelodysplastic SyndromesCytomegalovirus InfectionsDoxorubicinHematologic DiseasesPrednisonePOEMS SyndromeBlood Cell CountHLA AntigensMesenchymal Stem Cell TransplantationAntineoplastic AgentsAnemia, AplasticBlood CellsDexamethasoneFatal OutcomeBone MarrowLymphomaProspective StudiesRecombinant ProteinsCarboplatinLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow CellsBone Marrow PurgingLymphocyte DepletionCell DifferentiationCell TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaFlow CytometryT-LymphocytesFeasibility StudiesChimerismImmunophenotypingSiblingsEmbryonic Stem CellsOpportunistic InfectionsTransplantation ImmunologyKidney Transplantation